Speakers

Meet Our Speakers

The COVID Advocacy Exchange will invite close to 100 global and local advocacy organizations, spanning disease states, to convene virtually in their common pursuit of supporting patients with serious diseases who are simultaneously navigating the current COVID-19 pandemic. The virtual platform will provide access to data and information, as well as the opportunity to participate in weekly live, interactive sessions to foster discussion and collaboration.

Speakers for the June 11th: Safely Returning to Clinical Trials

Click on speaker name to see bio

Kathryn (Kate) Owen

Sr. Vice President, Global Development Operations, Bristol Myers Squibb

Kathleen Griffin

Executive Director, Partnerships and Digital Engagement, Syneos Health

Dr. Amy C. Moore

Director, Science & Research, GO2 Foundation for Lung Cancer

Upal Basu Roy, PhD, MPH

Vice President of Research, LUNGevity Foundation


Speakers for the June 4th: Going Virtual--Best Practices for Advocacy Organizations

Dave Fuehrer

CEO, and CoFounder, GRYT Health

Shwen Gwee

VP and Head of Global Digital Strategy, BMS

Lorna Warwick

CEO, Lymphoma Coalition

Nick Giallourakis

Co-Founder and President, Elephants and Tea

Crista Lopes

Professor, University of California, Irvine


Speakers for the May 28th: Coalitions & Collaboration

Pat Garcia-Gonzalez

CEO, The Max Foundation

Dr. Cary Adams

CEO, Union for International Cancer Control (UICC)

Trudie C A Lobban

MBE, Founder & Trustee, Arrhythmia Alliance, Founder & CEO, AF Association, Founder & CEO, STARS


Speakers for the May 21st: Welcome & Intro

Cathy Trzaskawka

Executive Director & Head, Global Advocacy, Bristol-Myers Squibb

Catherine Owen

Senior Vice President, Major Markets, Bristol-Myers Squibb

Wayne Eskridge

CEO, Fatty Liver Foundation

Seth D. Ginsberg

CO-Founder, Global Healthy Living Foundation (GHLF)

Andrea Vassalotti

Partnerships & Programmes Director, World Heart Federation

Gary Nolan

Managing Director, Scientific Education Support (SES)